Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GARY MICHAEL GOLDSTEIN

Allopathic & Osteopathic Physicians Pediatrics

NPI
1215995345
CMS profile
237004
Location
PALM HARBOR, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$2,063.89

92 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,978.90 91
Education $84.99 1

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GARY MICHAEL GOLDSTEIN

NPI 1215995345 · CMS profile ID 237004

Allopathic & Osteopathic Physicians / Pediatrics

PALM HARBOR, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1215995345?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GARY MICHAEL GOLDSTEIN, NPI 1215995345, CMS profile ID 237004. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1215995345?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). GARY MICHAEL GOLDSTEIN, NPI 1215995345, CMS profile ID 237004. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1215995345?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
GARY MICHAEL GOLDSTEIN, NPI 1215995345, CMS profile ID 237004, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1215995345?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

92 matching records · $2,063.89 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 92 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–92 of 92.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Bayer Healthcare Pharmaceuticals Inc. $22.5005/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086269882 CMS
Novo Nordisk Inc $22.2605/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096829529 CMS
SHIELD THERAPEUTICS INC $19.1105/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150130586 CMS
Novartis Pharmaceuticals Corporation $13.5005/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086852051 CMS
CorMedix Inc. $29.2205/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1082024392 CMS
AstraZeneca Pharmaceuticals LP $19.2005/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110546485 CMS
AstraZeneca Pharmaceuticals LP $19.7605/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110546463 CMS
Esperion Therapeutics, Inc. $16.7204/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1129436230 CMS
AstraZeneca Pharmaceuticals LP $14.5304/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110554098 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.5204/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117920947 CMS
AstraZeneca Pharmaceuticals LP $13.5604/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110533644 CMS
Lilly USA, LLC $21.8404/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134985076 CMS
Novo Nordisk Inc $19.2204/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097697414 CMS
Astellas Pharma US Inc $84.9904/08/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139346554 CMS
PFIZER INC. $13.9404/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131286160 CMS
PFIZER INC. $27.7104/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131212421 CMS
Lilly USA, LLC $20.8904/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134995050 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.3303/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153527363 CMS
Lilly USA, LLC $20.6803/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135001986 CMS
Nevro Corp. $18.6603/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1130782916 CMS
PFIZER INC. $15.1903/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131137363 CMS
Lilly USA, LLC $26.8003/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134984064 CMS
Sumitomo Pharma America, Inc. $18.1103/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148857227 CMS
ABBVIE INC. $32.7502/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103812652 CMS
Amgen Inc. $19.0802/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117262575 CMS
PFIZER INC. $17.4002/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131040416 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.3302/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086131688 CMS
Novo Nordisk Inc $23.2502/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096979546 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.1902/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153412777 CMS
PFIZER INC. $14.7602/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131137360 CMS
Lilly USA, LLC $26.1302/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134995048 CMS
Paratek Pharmaceuticals, Inc. $13.6802/07/2024 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 1113901647 CMS
ABBVIE INC. $125.0002/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103812650 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.8302/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117920943 CMS
Lilly USA, LLC $14.9102/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134977348 CMS
Lilly USA, LLC $23.9402/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135001868 CMS
Merck Sharp & Dohme LLC $19.1001/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141848722 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.6801/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086185924 CMS
Astellas Pharma US Inc $80.5201/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139378762 CMS
AstraZeneca Pharmaceuticals LP $24.7601/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110554050 CMS
SHIELD THERAPEUTICS INC $13.9801/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150117755 CMS
GlaxoSmithKline, LLC. $13.4601/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116367381 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,433.10 84
PY2020 $2,432.04 142
PY2021 $3,411.81 192
PY2022 $2,626.43 126
PY2023 $2,548.14 118
PY2024 $2,063.89 92
PY2025 $1,951.09 90

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $159,923.22 18
PY2024 Principal investigator $95,671.87 11
PY2023 Principal investigator $125,594.31 22
PY2022 Recipient $297.00 1
PY2022 Principal investigator $28,669.84 16
PY2021 Principal investigator $121,318.05 404
PY2020 Principal investigator $298,901.17 34
PY2019 Recipient $1,022.50 11
PY2019 Principal investigator $367,109.53 41

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

18 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,440.00 12/31/2025 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-attack Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Oral Ubrogepant in the Acute Treatment of Migraine With or Without Aura in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202532382
Principal investigator 1 Ionis Pharmaceuticals, Inc. $7,164.00 10/31/2025 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
IS354CS9 No dispute reported 06/30/2026 1246789946
Principal investigator 1 AstraZeneca Pharmaceuticals LP $10,351.86 10/15/2025 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event No dispute reported 06/30/2026 1185540083
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,275.00 10/10/2025 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
IS354CS9 No dispute reported 06/30/2026 1246788702
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,700.00 10/10/2025 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
IS354CS9 No dispute reported 06/30/2026 1246788706
Principal investigator 1 Ionis Pharmaceuticals, Inc. $12,917.10 10/10/2025 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
IS354CS9 No dispute reported 06/30/2026 1246788710
Principal investigator 1 AstraZeneca Pharmaceuticals LP $68,697.25 09/24/2025 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A Phase IIb Randomised, Double-blind, Placebocontrolled Study to Evaluate the Efficacy, Safety and Tolerability of Coadministration of AZD9550 and AZD6234 in Participants Living With Obesity or Overweight with Co-morbidity (ASCEND) No dispute reported 06/30/2026 1185540085
Principal investigator 1 AstraZeneca Pharmaceuticals LP $18,000.00 06/11/2025 Non-covered Recipient Entity
ROCHESTER CLINICAL RESEARCH
A Phase II Randomised Double blind Placebo controlled Study to Evaluate the Efficacy Safety and Tolerability of AZD5004 in Participants living with Obesity or Overweight with Comorbidity No dispute reported 06/30/2026 1185540087
Principal investigator 1 ABBVIE INC. $1,400.00 06/02/2025 Non-covered Recipient Entity
ATLAS INTERMEDIATE LLC
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202487277
Principal investigator 1 ABBVIE INC. $300.00 06/02/2025 Non-covered Recipient Entity
ATLAS INTERMEDIATE LLC
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202487279
Principal investigator 1 ABBVIE INC. $300.00 06/02/2025 Non-covered Recipient Entity
ATLAS INTERMEDIATE LLC
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202487281
Principal investigator 1 Eli Lilly and Company $3,968.00 05/27/2025 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PEDS1 No dispute reported 06/30/2026 1187893370
Principal investigator 1 ABBVIE INC. $1,850.80 04/03/2025 Non-covered Recipient Entity
ATLAS INTERMEDIATE LLC
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202472999
Principal investigator 1 ABBVIE INC. $1,400.00 03/06/2025 Non-covered Recipient Entity
ATLAS INTERMEDIATE LLC
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202457068
Principal investigator 1 ABBVIE INC. $1,440.60 03/06/2025 Non-covered Recipient Entity
ATLAS INTERMEDIATE LLC
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) No dispute reported 06/30/2026 1202457074
Principal investigator 1 Eli Lilly and Company $219.96 02/20/2025 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A PHASE 3, 12 MONTH, OPEN LABEL STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE PIONEER PEDS2 No dispute reported 06/30/2026 1187891236
Principal investigator 1 Eli Lilly and Company $26,836.00 02/11/2025 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
A PHASE 3, 12 MONTH, OPEN LABEL STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE PIONEER PEDS2 No dispute reported 06/30/2026 1187891096
Principal investigator 1 Eli Lilly and Company $662.65 01/31/2025 Non-covered Recipient Entity
SUNCOAST CLINICAL RESEARCH
PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PEDS1 No dispute reported 06/30/2026 1187893368